Software Facilitates Drug Candidate Analysis

This software initiative is intended to make the drug development cycle more effective and ultimately result in better drugs. The goal of the initiative is to help drug discovery scientists streamline the identification of viable drug candidates through better analysis of the absorption, distribution, metabolism and excretion (ADME) properties of compounds. U.S. government officials have estimated that the drug failure rate in pre-clinical stages of the development cycle is between 40 and 60 percent. To help lower the costly drug candidate failure rate within the pharmaceutical industry, software developments will focus on improving the timeliness and accuracy of information generated during ADME testing of the substances that can be developed into drugs.